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Background: Many patients with pneumonia and lower respiratory tract infection that could be treated as
outpatients according to their clinical severity score, are in fact admitted to hospital. We investigated whether,
with medical and social input, these patients could be discharged early and treated at home.
Objectives: (1) To assess the feasibility of providing an early supported discharge scheme for patients with
pneumonia and lower respiratory tract infection (2) To assess the patient acceptability of a study comprising of
randomisation to standard hospital care or early supported discharge scheme.
Methods: Design: Randomised controlled trial.
Setting: Liverpool, UK. Two University Teaching hospitals; one city-centre, 1 suburban in Liverpool, a city with high
deprivation scores and unemployment rates.
Participants: 200 patients screened: 14 community-dwelling patients requiring an acute hospital stay for pneumonia
or lower respiratory tract infection were recruited.
Intervention: Early supported discharge scheme to provide specialist respiratory care in a patient’s own home as a
substitute to acute hospital care.
Main outcome measures: Primary - patient acceptability. Secondary – safety/mortality, length of hospital stay,
readmission, patient/carer (or next of kin) satisfaction, functional status and symptom improvement.
Results: 42 of the 200 patients screened were eligible for early supported discharge; 10 were only identified at the
point of discharge, 18 declined participation and 14 were randomised to either early supported discharge or
standard hospital care. The total hospital length of hospital stay was 8.33 (1–31) days in standard hospital care and
3.4 (1–7) days in the early supported discharge scheme arm. In the early supported discharge scheme arm patient
carers reported higher satisfaction with care and there were less readmissions and hospital-acquired infections.
Limitations: A small study in a single city. This was a feasibility study and therefore not intended to compare
outcome data.
Conclusions: An early supported discharge scheme for patients with pneumonia and lower respiratory tract
infection was feasible. Larger numbers of patients would be eligible if future work included patients with dementia
and those residing in care homes.
Trial registration: ISRCTN25542492.
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Large variability in rates of hospitalisation for patients with
pneumonia and lower respiratory tract infection (LRTI)
exists across nearby geographical regions. Commentators
suggest that criteria for determining hospital admission
and length of stay (LOS) are uncertain, physician-depen-
dent and influenced by to socio-economic status and social
support [1-3]. Seventy percent of UK pneumonia admis-
sions are for patients with low-risk pneumonia (CURB-65
score 0–2) [4]; guidelines suggest that these patients do
not require admission however these patients account for a
significant proportion of bed days and costs [1]. Often, fac-
tors other than disease severity prompt or prolong hospital
admission such as the inability to cope at home alone or to
tolerate oral antibiotics, co-morbid illnesses, homelessness
and substance abuse [5,6]. With the provision of medical
support at home many more patients could be managed as
outpatients [7]. In Europe and the USA, 57% and 90% of
pneumonia/CAP (respectively) expenditure relates to the
cost of in-patient care [8,9]. Reduction of this resource bur-
den is an international priority.
For the elderly, in particular, hospital admission may
not only be unnecessary but also more detrimental com-
pared to care in their own residence, by increasing the
risk of confusion and hospital-acquired infection (HAI)
such as hospital acquired pneumonia (HAP) [10]. It is
therefore important to specifically address care provision
for elderly patients with respiratory tract infection by
providing the option of Hospital at Home (HAH).
HAH is defined as a service where active treatment is
provided by healthcare professionals in the patient’s
home for a condition that otherwise would require acute
hospital in-patient care, for a limited time period [11].
HAH schemes may aim for admission avoidance (AA)
[avoiding hospital admission altogether] and/or early
supported discharge (ESD) [discharging patients from
hospital earlier than standard hospital care (SHC) and
thereby reducing length of stay (LOS)].
Evidence of benefit in both AA and ESD schemes exists
in chronic obstructive pulmonary disease (COPD) [12-19].
The evidence base for HAH schemes in pneumonia and
LRTI is very limited. A recent expert review suggested that
supported home care for patients with CAP ‘shows enor-
mous potential for improving the care of elderly and dis-
abled patients, and should be further evaluated in terms of
efficacy and cost-effectiveness’ [20].
We prospectively studied the feasibility of a rando-
mised controlled study of an ESDS for patients with
pneumonia and LRTI: HOME Followed-up with Infec-
tion Respiratory Support Team (HOME FIRST).
Methods
We carried out a randomised feasibility study of an early
supported discharge scheme (ESDS) versus standardhospital care (SHC) for patients admitted to hospital
with pneumonia or LRTI. SHC in our city-centre teach-
ing hospital consists of patients being admitted through
the emergency department (self-presenting) or directly
to the acute medical admissions unit (AMAU) via their
GP. All patients that are to remain inpatients then stay
on AMAU for at least 12 hours in general prior to ward
transfer. On the AMAU the patient is clerked by a junior
doctor on the on-call team (this may be a foundation
year [FY] 1, 2, core medical trainee [CMT] or specialist
registrar). The patient is then reviewed by an acute med-
ical consultant within 12 hours on the post-take ward
round on AMAU prior to transfer to the medical ward;
this may be a general medical, respiratory or infectious
disease ward, depending on bed capacity. After this the
number and seniority of reviews differs per ward but in
general consultant wards rounds occur 2 – 3 times
weekly and registrar ward rounds once to twice weekly,
the patient is reviewed on a daily basis on week days by
a FY1, 2 or CMT trainee. Patients are referred to re-
spiratory medicine for specialist opinion as deemed ne-
cessary by their team.
Eligibility criteria
Patients ≥18 yrs old, admitted to hospital for pneumonia
or LRTI from January - April 2012 were considered for
recruitment. All CURB-65 scores were considered. In
order to participate, patients were required to meet
study eligibility criteria and provide written informed
consent. These criteria were designed to identify patients
suitable for this type of intervention (Table 1).
Randomisation and approval
Subjects were randomly assigned using computer gener-
ated random numbers to receive either ESDS or SHC.
Allocation was obtained by telephoning an independent
co-ordinator (closed envelope system). The local NHS
Research and Ethics Committee (REC North-West Liv-
erpool Central [11/NW/0670]) granted approval for the
study which was sponsored by Royal Liverpool and
Broadgreen Hospital trust (RLBUHT) and University
Hospital Aintree (UHA).
Study sites
The study was conducted at 2 sites, 1 city-centre Univer-
sity hospital (RLBUHT – 710 beds), one suburban Univer-
sity hospital (UHA – 743 beds) both within the same city.
Study intervention
We offered early supported discharge by providing spe-
cialist respiratory care to patients in their own home to
substitute acute hospital care. This care was provided by
an experienced hospital respiratory doctor and nurse
team who provided up to twice daily direct care and
Table 1 Selection criteria
Patient eligibility
Patients with any of the
following conditions:
• Pneumonia – CAP or HAP [radiological
consolidation and symptoms/signs of
respiratory infection] N.B. if CURB-65 ≥ 3
MUST have had at least 24hrs of in-
patient observation before recruitment.
• Non-pneumonic lower respiratory tract
infection [No radiological consolidation
but symptoms/signs of respiratory
infection]
• Pneumonia with concomitant COPD
(if this service is not provided elsewhere)
Inclusion criteria
Features on history • Patient able to give fully informed
consent
• Has a phone
• Age > 18yrs old
Features on examination
(stability indicator)
• Early warning score ≤2 (EWS, a score
calculated using baseline observations)
AND SBP > 90 AND mild confusion only
(Abbreviated mini-mental test score
[AMTS]≥ 7). All observations must be
stable for 12-24hrs
• Stable/improving inflammatory markers
(WCC/CRP)
• Stable/improving U&Es
Features of social situation • Can manage ADLs with current support
(immediate OT/physiotherapy/social
care can be arranged)
Exclusion criteria
Features on history • Well enough for discharge without
home care support
• No fixed abode
Features on examination
(instability indicator)
• SBP < 90 mmHg
• For patients with chronic respiratory
illness: saturations <88% on air
[except asthma]
• For patients without chronic respiratory
illness: saturations <92% on air
Features of diagnosis
(indicating cause for
concern)
• Suspected MI/raised TnI/T consistent
with NSTEMI within 5 days of discharge
• Empyema or complicated
parapneumonic effusion
• Tuberculosis suspected
• Neutropenia
• Acute exacerbations of COPD – infective
& non-infective (other services are already
provided)
• Serious co-morbidities requiring
hospital treatment (e.g: CKD, CCF) or
deemed unstable (significant AKD)
Features of social situation • Patients unable to manage at home
even with maximal support (e.g. IV
drug users, alcohol excess or mental
health problems)
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ical examinations. Oxygen [O2] (if not already receiving
domiciliary O2), intravenous (IV) fluids and IV antibi-
otics were not provided. The patient was followed by the
same study doctor until stable for discharge from the
ESDS, after this, care was provided by their general prac-
titioner as usual. Fast-access to discharge medications, a
disease-specific patient information leaflet and ‘meals-
on-wheels’ (ready-made food delivery service) were pro-
vided as required. SHC in our hospitals comprises of
both systematic, and as required, medical review.
Screening and recruitment
Potentially eligible patients were identified using a stand-
ard protocol. Only patients who would have required ‘at
least one more night of hospitalisation before discharge’
were considered. We hypothesised that various reasons
for this continued hospitalisation may exist, since there
is no specific guidance as to when a patient recovering
from LRTI is suitable for discharge and therefore inter-
physician variability exists. Where the study doctor con-
sidered a patient well enough for discharge without sup-
port, the usual medical team were notified. Subjects
were randomised to either SHC or ESDS. Age, gender
and reason(s) for a lack of eligibility/suitability were
noted for all screened patients. Patients already on home
O2 therapy were included in the study if their satura-
tions were >87% on their usual Fi02.
Recruited subjects provided a clinical history, were ex-
amined by the study doctor and completed an SF-12
questionnaire [21] (functional and quality of life assess-
ment tool) at day 0 and two CAP-SYM questionnaires
[22] (symptom score) for day 0 and day ‘minus 30’ (the
patient was asked to recall their symptoms from 30 days
prior to study recruitment). Nasal wash, serum, sputum,
blood cultures, clinical bloods and urine were obtained
at day 0. SF-12, CAP-SYM, nasal wash and serum (+/−
clinical bloods as needed) were performed on day 2
and 7; for patients who had been discharged, these in-
vestigations were performed in their home.
Subjects in the ESDS arm were transferred home the
same day with appropriate medications, an emergency
24 hr contact telephone number, a list of symptoms to
prompt healthcare contact (fever > 38° Celsius, increas-
ing drowsiness, worsening cough or sputum and/or in-
creasingly unwell) and an observations machine capable
of recording temperature, BP, HR and O2 saturations. If
the discharge was before 3 pm the subject was reviewed
at home later that evening by the team; if after 3 pm the
review was the next morning. The frequency and dur-
ation of home visits was determined by communication
between the medical team, patient and carer/next of
kin. Telephone calls were used instead of home visits
where the study team felt this suitable. Each visit lasted
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were recorded - BP, HR, O2 saturations and temperature
(on an observations form), clinical symptoms and exam-
ination findings, ability to eat/drink and appetite, bowel
habit, and current mobility/exercise tolerance. Ability
to cope at home and medication concordance were
assessed. Any evidence of confusion was thoroughly
assessed using the AMTS. Smoking advice was offered
and new issues, problems and symptoms were ad-
dressed. The case report form provided a guide for
recognising patients who needed consideration for re-
admission, using a simple set of clinical and functional
questions. Reasons for considering a patient suitable for
discharge from HOME FIRST included:
 Resolution of the reason for continued
hospitalisation
 Temp <37.5 degrees Celsius
 BP > 90 mm Hg
 Saturations > 86% on oxygen or 90% on air
 50% reduction in highest CRP (unless non-infective
reason for high CRP)
 Stable non-pneumonic co-morbidities (patient handed
over to community team if further follow-up needed)
 Able to manage with current care level
Reasons for readmission to hospital included:
 Social concern
 Reduced eating & drinking
 Fall
 Increasing CRP/WCC
 Unable to take antibiotics
 Oxygen saturations drop >2%
 RR rise ≥10
 Temp ≥38
 GCS drop ≥ 2
 No PU > 12 hrs
 Any other cause of clinical concern
Two weeks after recruitment all subjects and their
next of kin/carer received a telephone call from an inde-
pendent assessor to complete a care satisfaction ques-
tionnaire (see Additional file 1). All subjects were asked
to attend an outpatient appointment at 1 and 6 months
post recruitment; a clinical assessment, CAP-SYM, SF-12
and bloods (including serum) were performed.Outcomes and operational questions
This was a feasibility study with a primary outcome of
patient acceptability to randomisation. Data collected as
secondary outcomes included safety/mortality, patient/
carer satisfaction, readmission rates, total hospital LOS/days of care, functional status/quality of life and symp-
tom improvement. Cost was not assessed.
Safety
An experienced specialist respiratory doctor (a senior re-
spiratory registrar with more than 10 years of clinical ex-
perience) and respiratory nurses (band 6) with ward and
community experience used strict patient selection cri-
teria (see Table 1) such as ‘must have a telephone’, ‘must
be able to manage at home’ and minimum saturation
and BP thresholds to ensure patient safety. Subjects re-
ceived through education and a detailed information
leaflet with ‘red-flag’ symptoms (see Additional file 2).
The study team provided regular home visit and a 24 hr
telephone on-call service. Fast tracked re-admission was
arranged if deemed necessary.
Sample size and statistical methods
Our sample size was pragmatic allowing recruitment in
a single winter season. We planned to screen a mini-
mum of 100 patients, planning to recruit 20 subjects.
Results
During the 4-month study period 200 patients (with symp-
toms suggestive of respiratory infection) were screened.
158 were ineligible (see Table 2). Of the 42 eligible pa-
tients, 18 declined consent and 14 were randomised to
either SHC (n = 6) or ESDS (n = 8). The study profile is
summarised in Figure 1. The most common reason for
exclusion or non-recruitment was the inability to give
informed consent. The full range of reasons for non-
recruitment are shown in Table 2. Broadly these can be
categorised into medical reasons (66%), social reasons
(19%) and other reasons [‘missed’ or declined] (15%).
Patient consent
Of the remaining 32 eligible patients (after removal of
n = 10 who were ‘missed at repeat review’), 14 patients
consented to participation, 18 declined (see Figure 1).
The demographics and clinical characteristics of those
recruited and those who declined are shown in Table 3.
Reasons given by patients for not wishing to consent
included extra blood tests [n = 1], extra outpatient ap-
pointment [n = 1], ‘feel too unwell for home yet’ [n = 5]
and other (‘not keen on research’, ‘steep stairs’, ‘daughter
on holiday’) [n = 5].
The mean age of recruited patients was 64.6 (29-90)
yrs old; this was lower than in those whose NOK
declined consent. Subjects were allocated a CURB-65
score whether or not consolidation was seen on their
chest radiograph. New radiological consolidation was de-
fined as definite, possible or none; this was decided by
discussion between 2 respiratory clinicians. The median
CURB-65 of all recruited patients was 1 (range 0-3), the
Table 2 Reasons for non-recruitment
Reasons for non-recruitment N %
Confusion (Abbreviated Mini-mental Test Score [AMTS] <7) 37 20
Require more complex multi-disciplinary team [MDT] input
(physiotherapy, OT, social services)
35 19
Infective exacerbation of COPD [other services available] 20 11
Other co-morbidities requiring in patient stay 18 9.5
Clinical deterioration or mental health issues 17 9
Patient declined 13 7
Awaiting investigations to exclude pulmonary emboli 11 6
‘Missed’ 10 5
Too well (suitable for discharge without support) 10 5
Carer/next of kin (NOK) declined 5 2.5
Too hypoxic 4 2
No respiratory infection 3 2
INR issues 3 2
Total 186 100
NB: multiple reasons may apply for the same patient.
Figure 1 Screening and final recruitment numbers. Note no
patients withdrew consent or were lost to follow-up. ‘Missed’ means
missed due to logistical reasons e.g. by the time of repeat patient
review by the study team the patient was well enough for discharge
without ESDS support or the patient was discharged outside of the
hours/days of study recruitment.
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compared to all of those whose NOK declined who lived
alone. The average time from admission to recruitment
was 8 (1-9) days. Two recruited patients had positive
microbiology – one Haemophilus influenza in sputum,
the other Streptococcus pneumoniae in blood cultures.
Safety and efficacy of intervention
Two subjects from SHC, and none from ESDS were re-
admitted (within 30 days) of discharge. There was 1
death in ESDS arm (known palliative lung cancer) and 1
death in SHC arm (aspiration pneumonia on readmis-
sion – possible underlying lung malignancy). The total
LOS was 8.33 (1–31) days in SHC and 3.4 (1–7) days in
the ESDS arm respectively. One subject from the SHC
arm developed a presumed HAI. The maximum number
of home visits needed was 4 (generally 1–3). The total
length of stay in the ESDS was between 2–6 days. Sub-
ject and carer/NOK satisfaction (see table for example
questions and scoring) was generally good.
Twelve subjects completed all SF-12 questionnaires (see
Additional file 3) [day 0, 2, 7 and 28]. Overall mean in-
crease of 0.4 points/subject was seen in SHC, and 1 point/
subject in ESDS between day 0 and day 28. NB: using
the SF-36 (a similar questionnaire with 36 questions) a
20-point change in the scale is believed to represent a clin-
ically meaningful change; using SF-12 at least a 6-point
change is deemed necessary for clinical significance).
With regards to symptom improvement, using CAP-
SYM questionnaires,% recovery at day 28 (from baseline)
could only be calculated in 3 SHC and 6 ESDS patients;
with 88% and 90% recovery seen respectively at 28 days;
therefore no difference between the 2 groups.
During the study, we collated a table of the common
obstacles to recruitment (Table 4) that mainly refer to
staff practice within the hospitals.
Discussion
We have shown that using defined criteria for recruit-
ment and a defined interventional package, it is feasible
for some patients with LRTI and pneumonia, who would
otherwise have been treated in hospital, to be treated at
home. Using our current model however large numbers
of patients needed to be screened (n = 200) in order to
recruit low numbers (n = 14). The ESDS package was
successfully implemented in 7 patients with no adverse
events. Randomisation was acceptable to patients and
only deters those who do not wish to go home. The
main obstacle to eligibility was lack of capacity to give
informed consent. The number of eligible patients could
be doubled if chronically confused or demented patients
were included. Virtual visits (via telephone), rather than
home visits may be adequate after the first 48 hrs after
discharge.
Table 3 Demographics and characteristics of patients who declined or were recruited
Declined Recruited
Patient (n = 13) NOK (n = 5) SHC (n = 6) ESDS (n = 8)
Age (mean [range]) 66 [25 – 84] 79 [68 – 87] 70 [52 – 90] 61 [29 – 82]
Gender (M:F) 6 : 7 3 : 2 2 : 4 5 : 3
Smoking status Not recorded Ex – 3 Ex – 3
Current – 2 Current – 2
Never – 1 Never – 3
Social history Live alone – 4 Live alone – 5 Live alone – 3 Live alone – 1
With spouse – 6 With spouse – 2 With spouse – 5
With family – 3 With family – 1 With family – 2
CURB–65 (median [range]) Not recorded 2 [1 – 3] 1 [0 – 2]
Total hospital LOS (mean days [range]) 8.33 [1 – 31] 3.4 [1 – 7]
New radiological consolidation Definite – 5 Definite – 4
Possible – 0 Possible – 2
None – 1 None – 2
Age, gender, smoking status and social history were recorded from screening data.
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have been able to recognise common recruitment obsta-
cles and find solutions to aid future project develop-
ment. It has been noted previously in similar schemes
that patient/carer refusal tends to reduce if a scheme be-
comes an adopted hospital service rather than a research
project.
The weaknesses of this study are that it is a small
feasibility study in a single city therefore no powered
outcome data is available. The criterion of ‘requiring at
least one more night of hospitalisation’ may be consid-
ered by some to be a weak criterion. The overall aim of
the study is to reduce hospital bed days within a ‘real-
life’ hospital setting in the UK. One more night of hospi-
talisation may be due to a variety of reasons and cannot
simply be defined according to pre-defined signs or
symptoms, as appropriate time for discharge for a pa-
tient with LRTI is physician-specific and no specific
guidelines exist. We considered reasons that a patient
would have ‘taken up’ a bed in hospital for at least one
more night if ESDS were not available, these included:Table 4 Common obstacles to recruitment
Medical • Pneumonia may be a vague diagnosis in hospital
practice therefore large numbers of patients with
respiratory infection need to be screened to find
eligible patients
• Lack of capacity to give consent
Staff • Lack of physician ‘buy-in’ and resistance to change
Social • Hospital stay may be seen as a respite opportunity
for some carers
Patient belief • Some patients believe that they must be
100% better before hospital discharge; some
were suspicious of a new or research-based service.the need for further daily INR checks and low molecular
weight heparin administration (with no facilities to have
this performed immediately daily in the community),
physician suggesting a further period of inpatient review
for at least 24 hours after having changed from intraven-
ous to oral antibiotics to ensure no pyrexia develops, no
ability to get food supplies in at the patient’s home until
the next day and insufficient ward staff to organise oxy-
gen delivery and transport the same day, all leading to
delayed discharge. All patients recruited received more
intensive medical care than standard hospital care due
to clinician sampling visits; this may affect the results of
satisfaction questionnaires. Questionnaire data may be
subject to recall bias. Also day 0 was defined as the day
that the patient was deemed fit to be discharged home
with support and not the first day of illness or day of ad-
mission; therefore this may not have captured the peak
impact of the illness on their symptoms.
Our study, like previous studies of AA and ESDS
for CAP and LRTI have shown recruitment may be
difficult. In one study, 985 patients needed to be
screened to find 214 eligible and 84 recruits, of which
53 had a diagnosis of CAP [23], in another 540 were
screened to recruit 25 in each arm of study [24]. Low
programme acceptance has been noted due to decline
by physician (11%), patient (38%) or next of kin
(36%) [25]. A study recruiting 55 patients with CAP
in New Zealand in 2005 showed improved patient
satisfaction by 40% (p < 0.001) and improved sleep
but increased total days of care and no improvement
in symptom score or function at 2 & 6 weeks [24].
Other studies have shown reduced bed days and
hospitalisation (12% reduction) and overall cost re-
ductions of $1489 and $(CAN)1016 [23,26].
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where two reviewers used pre-defined inclusion and ex-
clusion criteria to assess eligibility to an ESDS, 48% of
patients were deemed suitable for early supported dis-
charge. The mean age of patients was 70 yrs old (range
18–96), 58% CURB-65 ≤ 2 and co-morbidities were com-
mon; COPD (30%) and dementia (15%). The total poten-
tial reduction in length of stay was calculated at 2.75
(range 1–7) days; amounting to a potential saving of
687,500 bed days annually in England [27].
The potential patient-related (reduced risk of HAI,
care in own home, improved sleep, increased recovery
rate, improved patient and carer satisfaction, reduced
risk of delirium and later post-hospital discharge institu-
tionalisation) and health-service benefits (reduced risk of
HAI, improved self-management, reduced hospital LOS
and therefore cost) are critical in assessing service im-
pact. Strategies to increase the proportion of low-risk
patients with CAP treated in the community have been
developed and have been reported as safe, effective and
acceptable to patients [28]. There is an urgent need for
more evidence regarding ESDS to facilitate the discharge
of patients with more complicated needs, due to the
increasing bed pressures on acute hospital trusts. A sig-
nificant number of patients who have complex social/
mental health needs or co-morbidities will however still
require inpatient care.
Future developments to our model may include accept-
ing patients in whom clear decisions have been made that
no escalation in care is appropriate if after 48 hrs no im-
provement is seen as terminal care may be more appropri-
ately delivered at home [29]. Accepting patients on IV
antibiotics and developing closer links with ‘early response
teams’ in order to facilitate fast and effective discharge of
more complex patients may be useful, as the numbers of
hospital beds reduce in the UK [11].
We interpret our data to indicate that to improve
recruitment future study directions should include: (1)
Hospital logistics - working with hospital management to
improve hospital systems to reduce time spent screening
ineligible patients, increasing recruitment hours up to
12 hours-per-day, 7-days-per-week and improved ESDS
‘marketing’ (2) Medical conditions - the use of consultee
declarations and retrospective consent allowing recruit-
ment of suitable patients who lack capacity (3) Staff - im-
proving physician education with regards to pneumonia
and LRTI diagnosis and PE risk in order to reduce over-
investigation/defensive practice, better study and clinical
team integration (knowledge that the study team can re-
duce the team’s workload by facilitating discharge and
conducting out-patient appointments) thereby decreasing
physician refusal and earlier patient contact with the study
team, enabling closer relationships to be formed thereby
reducing the likelihood of ‘mixed messages’.We estimate that by implementing the various methods
described to overcome barriers to recruitment we could
improve recruitment by 37.5%.
Conclusion
In conclusion, an ESDS is difficult but not impossible to
implement. Large numbers are needed to effectively assess
safety and effectiveness. HAH care is a complex clinical
model [30] that may work best as part of a portfolio of
models (both AA and ESDS) promoting the for patients
with respiratory infection [31]. HAH presents an oppor-
tunity to improve health policy, healthcare delivery and
services; and to reduce admission rates and HAIs, all areas
of major strategic importance internationally. We propose
a large RCT with multiple relevant patient-related end-
points is urgently needed [27].
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Additional file 1: Satisfaction (Patient and Carer) Survey Questionnaire.
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